lavendustin a and Breast Neoplasms studies

lavendustin a and Breast Neoplasms

lavendustin a has been researched along with Breast Neoplasms in 3 studies

lavendustin A: from Streptomyces griseolavendus; structure given in first source

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

Excerpt	Relevance	Reference
"We have investigated the anti-proliferative effect of the tyrosine kinase inhibitors genistein, lavendustin A and 2,5-dihydromethylcinnimate (2,5-MeC) (a stable erbstatin analogue) against the epidermoid A431 cell line, the ZR-75-1 human breast cancer cell line and tamoxifen-resistant (ZR-75-9a1) and oestrogen-independent (ZR-PR-LT) variants."	7.70	The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine ( El-Zarruk, AA; van den Berg, HW, 1999)
"We have investigated the anti-proliferative effect of the tyrosine kinase inhibitors genistein, lavendustin A and 2,5-dihydromethylcinnimate (2,5-MeC) (a stable erbstatin analogue) against the epidermoid A431 cell line, the ZR-75-1 human breast cancer cell line and tamoxifen-resistant (ZR-75-9a1) and oestrogen-independent (ZR-PR-LT) variants."	3.70	The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine ( El-Zarruk, AA; van den Berg, HW, 1999)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

2 (66.67)

18.2507

2000's

1 (33.33)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Zhou, JN	1
Ljungdahl, S	1
Shoshan, MC	1
Swedenborg, J	1
Linder, S	1
El-Zarruk, AA	1
van den Berg, HW	1
Mandal, S	1
Richardson, VJ	1
Banoub, J	1
Church, JG	1

Studies

Zhou, JN

Ljungdahl, S

Shoshan, MC

Swedenborg, J

Linder, S

El-Zarruk, AA

van den Berg, HW

Mandal, S

Richardson, VJ

Banoub, J

Church, JG

Other Studies

3 other studies available for lavendustin a and Breast Neoplasms

Article	Year
Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway. Molecular carcinogenesis, 1998, Volume: 21, Issue:4 Topics: Base Sequence; Benzoquinones; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Dactin	1998
The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine Cancer letters, 1999, Aug-03, Volume: 142, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cinnamates; Dose-Response Relationship, Drug	1999
Identification of myo-inositol 1,2-cyclic monophosphate by electrospray tandem mass spectrometry, a major constituent of EGF-stimulated phosphoinositide turnover in MDA 468 cells. Experimental cell research, 2002, Jul-15, Volume: 277, Issue:2 Topics: Acids; Breast Neoplasms; Chromatography, High Pressure Liquid; Epidermal Growth Factor; Female; Huma	2002

Article

Year

Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway.

Molecular carcinogenesis, 1998, Volume: 21, Issue:4

Topics: Base Sequence; Benzoquinones; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Dactin

1998

The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine

Cancer letters, 1999, Aug-03, Volume: 142, Issue:2

Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cinnamates; Dose-Response Relationship, Drug

1999

Identification of myo-inositol 1,2-cyclic monophosphate by electrospray tandem mass spectrometry, a major constituent of EGF-stimulated phosphoinositide turnover in MDA 468 cells.

Experimental cell research, 2002, Jul-15, Volume: 277, Issue:2

Topics: Acids; Breast Neoplasms; Chromatography, High Pressure Liquid; Epidermal Growth Factor; Female; Huma

2002